MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2026 International Congress

    Does Subthalamic Nucleus DBS Produce Sustained Improvement in Postural Abnormalities? A 5 Year Prospective Study

    M. Siddiqui, R. Shivacharan (Winston Salem, USA)

    Objective: To evaluate the long-term effects of subthalamic nucleus (STN) deep brain stimulation (DBS) on postural abnormalities in patients with advanced Parkinson’s disease (PD). Background:…
  • 2026 International Congress

    Motor and Non-motor Outcomes of Globus Pallidus internus Deep Brain Stimulation for Dystonia

    V. S Rangan, V. Bharath, V. Yerramneni, S. Yareeda (Hyderabad, India)

    Objective: This study aims to assess the response to GPi DBS in patients presenting with various types of dystonia and to co-relate the motor as…
  • 2026 International Congress

    A Specialized 3D-Printed Device for Gait Rehabilitation in Parkinson’s: Development and Application.

    S. Ismailova, S. Prokopenko (Krasnoyarsk, Russian Federation)

    Objective: To develop and evaluate the efficacy of a specialized 3D-printed device designed to correct gait disorders in Parkinson's disease by enhancing step initiation via…
  • 2026 International Congress

    Hepatic Biomarker Profile Across Parkinson’s Disease Severity Stages in a Peruvian Cohort

    J. Moya-Salazar, F. Peralta-Hilario, I. Pasco, B. Cañari, A. Sobrino-Galindo, H. Contreras-Pulache (Chiclayo, Peru)

    Objective: To determine changes in serum hepatic biomarker concentrations according to Parkinson's disease (PD) severity in Peruvian adults. Background: PD is a progressive neurodegenerative disorder.…
  • 2026 International Congress

    Clinical Stage According to Hoehn & Yahr Scale as a Predictor of Non-Motor Symptom Severity in Parkinson’s Disease: A Cross-Sectional in Peru

    J. Moya-Salazar, A. Sobrino-Galindo, B. Cañari (Chiclayo, Peru)

    Objective: To determine the association between clinical stage of Parkinson's disease (PD), according to the Hoehn & Yahr (H&Y) scale, and the severity of non-motor…
  • 2026 International Congress

    Blood glucose homeostasis is conserved in patients with mild to moderate Spinocerebellar Ataxia type 2

    R. Aguilera-Rodríguez, D. Almaguer-Gotay, A. álvarez-Sosa, M. Anidos-Machado, Y. Silva-Ricardo, D. Cuello-Almarales, A. Estupiñán-Rodríguez, L. Almaguer-Mederos (Holguín, Cuba)

    Objective: To explore novel molecular biomarker candidates for SCA2, based on the assessment of blood glucose homeostasis. Background: Spinocerebellar ataxia type 2 (SCA2) is a…
  • 2026 International Congress

    Dual-Task Cost Assessment in Parkinson’s Disease: A Literature Review of Clinical Applications and Measurement Approaches

    C. Balasubramanian, Z. Board, J. Thomas, H. Malik, S. Bagdadi, I. Khan, K. Mangipudi (Jacksonville, USA)

    Objective: This literature review examines current evidence on dual-task cost assessment in PD, focusing on measurement approaches, clinical relevance, and factors influencing performance. Background: Parkinson’s…
  • 2026 International Congress

    A Clinical Mapping Framework for Motor Balance Impairment in Welders Projected Against Parkinson Disease Severity Stages

    S. Narayanan, A. Alkinani, S. Ramesh, M. Thyagarajan, V. Krishnan Muthaiah (Buffalo, USA)

    Objective: To determine whether welders exhibit Parkinsonian-like motor balance phenotypes by projecting clinical balance scores into Hoehn and Yahr severity space using a PD-trained predictive…
  • 2026 International Congress

    Genotype-Phenotype Correlations in KCNMA1 Channelopathy: A Comparative Analysis of Gain-of-Function and Loss-of-Function Variants in a Korean Cohort and Literature Review

    JM. Kim, S. Lee, SY. Kim, J. Moon, JH. Chae (Seoul, Republic of Korea)

    Objective: The objectives of this study are to delineate the distinct genotype-phenotype correlations between gain-of-function and loss-of-function KCNMA1 variants by analyzing a novel clinical cohort…
  • 2026 International Congress

    Ulixacaltamide Demonstrates Superiority Over Placebo as Monotherapy and as Add-on to Propranolol in Essential Tremor: Phase 3 ESSENTIAL3 Study 1

    M. Souza, S. Petrou, M. Sniecinski, C. Santos, M. Giroux, M. Steidle, J. Farmer, S. Brillman, A. Shtilbans (Boston, USA)

    Objective: To evaluate efficacy of ulixacaltamide, a selective T-type calcium channel modulator, versus placebo in adults with essential tremor (ET) as monotherapy and as add-on…
  • « Previous Page
  • 1
  • …
  • 50
  • 51
  • 52
  • 53
  • 54
  • …
  • 208
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley